US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
The products are far from a proven sleep treatment.
Americans love working from home. Does it love them back? A controversial new study says remote work is taking a toll on ...
The prevalence of overweight and obesity represents a global public health challenge 1. Incretin mimetic therapies, including glucagon-like peptide 1 (GLP-1) receptor agonists and dual ...
Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?
A transgender teen tested Roo, Planned Parenthood's AI-powered sexual health chatbot, which includes LGBTQ+ health topics, ...
Morning Overview on MSN
An experimental drug doubled one-year survival for pancreatic cancer patients
Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...
Morning Overview on MSN
A large review argues mental decline isn’t inevitable and the brain can still gain at any age
A systematic review of learning across the adult lifespan, published in Neuroscience and Biobehavioral Reviews, concludes ...
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results